The text here forms part of the terms and conditions of use that every Raymedi International user must accept before being provided with access to the Raymedi International Learning Portal, which sits on the quality aspects and standardization marked by the Accreditation partner ACTD.

If you have any queries about any aspect of these terms and conditions, please contact info@raymediinternational.com. Using the Raymedi International Learning Portal In consideration of your having paid, and Raymedi International having accepted, a course fee, Raymedi International
grants you, the End User, rights to access the Training Content subject to acceptance of these Terms and Conditions as set out below.
Raymedi International has an Agreement with the Training Content Developers which is subject to conditions which cannot be varied and which are reflected in this End User License.

By accessing the Training Content you, the End User, accept the following conditions: You agree to use this site only for lawful purposes, and in a manner that does not infringe the rights of, or restrict or inhibit the use and enjoyment of this site by any third party. Such restriction or inhibition includes, without limitation, conduct which is unlawful, or which may harass or cause distress or inconvenience to any person, and the transmission of obscene or offensive content or disruption of normal flow of dialogue within this site. Neither Raymedi International, nor any Agent distributing Licences on behalf of Raymedi International, nor the Training Content Developers, make any specific claims about the suitability of the Training Content for any particular purposes. The suitability of the Training Content to your, the End User’s, needs is wholly a matter for your judgement.

To the maximum extent allowed by law, Raymedi International excludes all claims against it howsoever arising from use of the Training Content in circumstances for which it is inappropriate. While reasonable professional care has been taken in developing the educational and research Content, Raymedi International make no warranties concerning the correctness or completeness of the Training Content.To the maximum extent allowed by law, Raymedi International excludes all claims against it arising from errors or omissions in the Training Content. Log-in codes or passwords required to access the Training Content are provided for single person use only and cannot be shared with anyone else unless the commercial terms under which the License is issued specifically allow for multiple use under a separate contract signed by both the parties legally. You are required to take reasonable measures to prevent unauthorized use by others and to report such use to Raymedi International. You accept liability for any losses to Raymedi International arising from your deliberately sharing log-in codes or your failure to show appropriate diligence in keeping your code confidential.

Raymedi International does not undertake to provide availability to the Training Content at any specific time. Under the conditions of this Licence, Raymedi International specifically excludes liability to you or any third party for losses arising from the non availability of access to the Training Content at any particular time. If you provide evidence that the general availability of access is inferior to that which could be expected under normal industry standards because of failure on the part of Raymedi International, Raymedi International may provide compensation which will not in any event exceed the price paid by you, or on your behalf, to purchase this Licence.

All these courses are not recognized by any Government bodies including Medical Council of India, American or UK Government bodies.

Raymedi International Subscription Services Licences are purchased for twelve months on a single-user basis. Organisations purchasing multiple
Licences can purchase Licences for End Users and upload the Licences at any time within 12-months of the invoice date. Once uploaded, Licences expire after 12-months. When selecting a monthly subscription option, you accept that: